Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

Amlodipine besylate; olmesartan medoxomil - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amlodipine besylate; olmesartan medoxomil and what is the scope of freedom to operate?

Amlodipine besylate; olmesartan medoxomil
is the generic ingredient in two branded drugs marketed by Daiichi Sankyo, Ajanta Pharma Ltd, Torrent Pharms Llc, Teva Pharms Usa, and Macleods Pharms Ltd, and is included in five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Amlodipine besylate; olmesartan medoxomil has ninety-eight patent family members in twenty-seven countries.

There are forty-nine drug master file entries for amlodipine besylate; olmesartan medoxomil. Seven suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: amlodipine besylate; olmesartan medoxomil

Tradenames:2
Patents:2
Applicants:5
NDAs:5
Drug Master File Entries: see list49
Suppliers / Packagers: see list7
Clinical Trials: see list175
Drug Prices:see low prices
DailyMed Link:amlodipine besylate; olmesartan medoxomil at DailyMed

Pharmacology for Ingredient: amlodipine besylate; olmesartan medoxomil

Tentative approvals for AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Applicant Application No. Form Dosage
► Subscribe► SubscribeTABLET; ORAL5MG/20MG
► Subscribe► SubscribeTABLET; ORAL5MG/40MG
► Subscribe► SubscribeTABLET; ORAL10MG/20MG
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Macleods Pharms Ltd
AMLODIPINE AND OLMESARTAN MEDOXOMIL
amlodipine besylate; olmesartan medoxomil
TABLET;ORAL206884-003Oct 26, 2016ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
AMLODIPINE AND OLMESARTAN MEDOXOMIL
amlodipine besylate; olmesartan medoxomil
TABLET;ORAL091154-001Oct 26, 2016ABRXNoNo► Subscribe► Subscribe
Ajanta Pharma Ltd
AMLODIPINE AND OLMESARTAN MEDOXOMIL
amlodipine besylate; olmesartan medoxomil
TABLET;ORAL207216-001Oct 28, 2016ABRXNoNo► Subscribe► Subscribe
Daiichi Sankyo
AZOR
amlodipine besylate; olmesartan medoxomil
TABLET;ORAL022100-004Sep 26, 2007ABRXYesYes5,616,599*PED► Subscribe ► Subscribe
Torrent Pharms Llc
AMLODIPINE AND OLMESARTAN MEDOXOMIL
amlodipine besylate; olmesartan medoxomil
TABLET;ORAL202933-002Nov 25, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot